We require Idiopathic Pulmonary Fibrosis (IPF) patients who also have a diagnosis of Obstructive Sleep Apnoea (OSA) for a new study.
This study will be 2 to 3 visits to the unit, and will be spread over approximately 1 to 4 weeks.
A payment will be made on completion of the study for your time, travel expenses and to compensate for any inconvenience.
gender: Female
Idiopathic Pulmonary Fibrosis (IPF) – 8 Weeks
We require Idiopathic Pulmonary Fibrosis (IPF) patients for a new study.
This study will be 2 to 4 visits to the unit and two phone calls, and will be spread over approximately 4 to 8 weeks.
A payment will be made on completion of the study for your time, travel expenses and to compensate for any inconvenience.
Asthma – 11 Weeks
We require mild asthmatics for a new study.
This study will be approximately 9 visits to the unit, including 7 one-night residential stays and will be spread over approximately 4-11 weeks.
A payment will be made on completion of the study for your time, travel expenses and to compensate for any inconvenience.
Psoriasis – 11 Weeks
We require both male and female psoriasis patients between the ages of 18 and 65 for a new study. This study will be approximately 3 visits to the unit, including one 19 night stay at the clinical trial unit and will be spread over approximately 4-11 weeks.
A payment will be made on completion of the study for your time, travel expenses and to compensate for any inconvenience.
Healthy Volunteer – 11 Weeks
We require both male and female healthy volunteers between the ages of 18 and 65 for a new study.
This study will be approximately 3 visits to the unit, including one 19 night stay at the clinical trial unit and will be spread over approximately 4-11 weeks.
A payment will be made on completion of the study for your time, travel expenses and to compensate for any inconvenience.
Asthma – 14 Months
We require asthma patients for a new study.
This study will be approximately 10 visits to the unit and 1 phone contact, and will spread over approximately 14 months.
A payment will be made on completion of the study for your time, travel expenses and to compensate for any inconvenience.
Alpha-1 Antitrypsin Deficiency (AATD) – 11 Months
We require patients with Alpha-1 Antitrypsin Deficiency (AATD) and Emphysema for a new study.
This study will be approximately 37 visits to the unit and will spread over approximately 11-12 months.
A payment will be made on completion of the study for your time, travel expenses and to compensate for any inconvenience.
Asthma – 8 Months
We require patients with asthma for a new study.
This study will be approximately 10 visits to the unit and will spread over approximately 32 weeks.
A payment will be made on completion of the study for your time, travel expenses and to compensate for any inconvenience.
Asthma – 11 Weeks
We require patients with asthma for a new study.
This study will be approximately 8 visits to the unit and will spread over approximately 11 weeks.
A payment will be made on completion of the study for your time, travel expenses and to compensate for any inconvenience.
Eczema – 8 Months
We require patients with eczema for a new study.
This study will be approximately 17 visits to the unit and will spread over approximately 8-9 months.
A payment will be made on completion of the study for your time, travel expenses and to compensate for any inconvenience.